Pharmacokinetics of intravitreal 5-fluorouracil prodrugs in silicone oil: experimental studies in pigs

被引:15
作者
Laugesen, CS
Steffansen, B
Scherfig, E
la Cour, M
机构
[1] Natl Univ Hosp, Rigshosp, Eye Dept, DK-2730 Herlev, Denmark
[2] Danish Univ Pharmaceut Sci, Dept Pharmaceut, Copenhagen, Denmark
[3] Univ Copenhagen, Herlev Hosp, Eye Dept, Copenhagen, Denmark
[4] Univ Copenhagen, Eye Pathol Inst, Copenhagen, Denmark
来源
ACTA OPHTHALMOLOGICA SCANDINAVICA | 2005年 / 83卷 / 02期
关键词
5-fluorouracil; prodrugs; controlled release; ocular drug delivery; proliferative vitreoretinopathy;
D O I
10.1111/j.1600-0420.2005.00429.x
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose: To examine the in vivo pharmacokinetics of intravitreal 5-Fluorouracil (5-FU) following tamponade with 5-FU prodrug silicone oil formulations. Method: Two different alkoxycarbonyl 5-FU prodrugs denoted C12 and C18 were synthesized and formulated as silicone oil suspensions. A total of 26 pigs underwent conventional three-port lens-sparing pars plana vitrectomy. Approximately 1.6 ml of the prodrug-silicone oil formulation was placed in the vitreous cavity. Operated eyes were enucleated between 20 min and 168 hours postoperatively, and analysed for their content of free 5-FU by high performance liquid chromatography. Results: With the C12 prodrug silicone oil formulation, the concentration of free 5-FU in the vitreous water phase 1 hour after surgery was 3.30 +/- 1.62 mu g/ml. After 4 hours this concentration had declined to 1 mu g/ ml. With the C18 prodrug, the concentration of free vitreal 5-FU never reached 1 mu g/ml during the 7 days these experiments lasted. A mathematical model is presented that can explain the measured data if the clearance of 5-FU from the vitreous water phase follows first order kinetics with a half-life of 20 min. Conclusion: These experiments, and the model analysis, suggest that the elimination half-life of 5-FU in the vitreous cavity of a vitrectomized, silicone oilfilled eye is very fast. The model analysis indicates that an alkoxycarbonyl 5-FU prodrug with a specific release rate constant of 10.7 mu g/(root h cm(2)) can maintain an intravitreal 5-FU concentration above 1 mu g/ml for 5 days in the porcine eye.
引用
收藏
页码:184 / 190
页数:7
相关论文
共 25 条
[1]
HYPOTONIC MACULOPATHY AFTER TRABECULECTOMY WITH POSTOPERATIVE USE OF 5-FLUOROURACIL [J].
ALTAN, T ;
TEMEL, A ;
BAVBEK, T ;
KAZOKOGLU, H .
OPHTHALMOLOGICA, 1994, 208 (06) :318-320
[2]
Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy - Results from a randomized, double-blind, controlled clinical trial [J].
Asaria, RHY ;
Kon, CH ;
Bunce, C ;
Charteris, DG ;
Wong, D ;
Khaw, PT ;
Aylward, GW .
OPHTHALMOLOGY, 2001, 108 (07) :1179-1183
[3]
AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P780
[4]
Berger AS, 1996, INVEST OPHTH VIS SCI, V37, P2318
[5]
BLUMENKRANZ M, 1984, OPHTHALMOLOGY, V91, P122
[6]
SELECTION OF THERAPEUTIC AGENTS FOR INTRAOCULAR PROLIFERATIVE DISEASE .2. DIFFERING ANTIPROLIFERATIVE ACTIVITY OF THE FLUOROPYRIMIDINES [J].
BLUMENKRANZ, MS ;
HARTZER, MK ;
HAJEK, AS .
ARCHIVES OF OPHTHALMOLOGY, 1987, 105 (03) :396-399
[7]
FLUOROURACIL FOR THE TREATMENT OF MASSIVE PERIRETINAL PROLIFERATION [J].
BLUMENKRANZ, MS ;
OPHIR, A ;
CLAFLIN, AJ ;
HAJEK, A .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (04) :458-467
[8]
BUNTMILAM AH, 1985, INVEST OPHTH VIS SCI, V26, P1377
[9]
PRODRUGS OF 5-FLUOROURACIL .5. 1-ALKOXYCARBONYL DERIVATIVES AS POTENTIAL PRODRUG FORMS FOR IMPROVED RECTAL OR ORAL DELIVERY OF 5-FLUOROURACIL [J].
BUUR, A ;
BUNDGAARD, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (05) :522-527
[10]
CAMPOCHIARO PA, 2001, RETINA, P2221